Vancomycin-Associated Leukocytoclastic Vasculitis
Case Reports in Infectious Diseases · 2011
DOI: 10.1155/2011/356370 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Infectious Diseases, 2011. Verfasst von Makhawadee Pongruangporn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCRR NIH HHS.
Abstract (Originalsprache)
Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin. Skin biopsy revealed leukocytoclastic vasculitis.
Autor:innen und Institutionen
- Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.
Förderung
- NCRR NIH HHS
Zitieren
APA
Pongruangporn, M., Ritchie, D. J., Lu, D., & Marschall, J. (2011). Vancomycin-Associated Leukocytoclastic Vasculitis. Case Reports in Infectious Diseases. https://doi.org/10.1155/2011/356370
Vancouver
Pongruangporn M, Ritchie DJ, Lu D, Marschall J. Vancomycin-Associated Leukocytoclastic Vasculitis. Case Reports in Infectious Diseases. 2011. doi:10.1155/2011/356370
BibTeX
@article{Pongruangporn2011,
author = {Pongruangporn, Makhawadee and Ritchie, David J and Lu, Dongsi and Marschall, Jonas},
title = {Vancomycin-Associated Leukocytoclastic Vasculitis},
journal = {Case Reports in Infectious Diseases},
year = {2011},
doi = {10.1155/2011/356370}
}
EUVIMED